Phospholipid-Based Prodrugs for Drug Targeting in Inflammatory Bowel Disease: Computational Optimization and In-Vitro Correlation

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|23|2543-2548

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.23, 2016-07, pp. : 2543-2548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azo Reductase- Activated Colon- Targeting Prodrugs of Aminosalicylates for Inflammatory Bowel Disease: Preparation, Pharmacokinetic and Pharmacodynamic Profile

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 6, 2013-12 ,pp. : 419-432

Bentham Science Publishers

Access to resources Recommend Favorite

Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach

By  

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 740-747

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib

By Tamilvanan S.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 761-771

Informa Healthcare

Access to resources Recommend Favorite

In-vitro and In-vivo Correlation [IVIVC] for Nanoparticulate Drug Delivery Systems

By  

Drug Delivery Letters, Vol. 7, Iss. 3, 2017-11 ,pp. : 181-189

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Treatment Options for Inflammatory Bowel Disease: Targeting α4 Integrin

By Lanzarotto Francesco   Carpani Marta   Chaudhary Rakesh   Ghosh Subrata  

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1179-1189

Adis International

Access to resources Recommend Favorite